NewsBenzingaAbivax To Present Seven Scientific Abstracts On Obefazimod, Lead Drug Candidate For Treatment Of Active Ulcerative Colitis At UEG Week 2026 Meeting Abivax To Present Seven Scientific Abstracts On Obefazimod, Lead Drug Candidate For Treatment Of Active Ulcerative Colitis At UEG Week 2026 Meeting Benzinga 2026.09.30 20:16 (GMT+0) Open on Benzinga Other news If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much Today Here’s How Much You Would Have Made Owning WESCO International Stock In The Last 10 Years Google shows it’s not out of the AI race just yet Here's How Much $100 Invested In NXP Semiconductors 15 Years Ago Would Be Worth Today Here's How Much $1000 Invested In Bank of New York Mellon 15 Years Ago Would Be Worth Today Nancy Pelosi Owns This Hot 2026 Stock — And LeBron James Is About to Wear It
